ROCHE BOBOIS financials
ROCHE BOBOIS
969500JZSD8O83SPU920 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €402.5M | €414.0M |
| Employee benefits expense | €89.9M | €90.0M |
| Raw materials & consumables used | €141.0M | €143.9M |
| Depreciation & amortisation | €48.2M | €46.9M |
| Operating profit (EBIT) | €21.8M | €26.1M |
| Profit before tax | €14.0M | €21.5M |
| Income tax expense | €3.8M | €5.7M |
| Profit for the year | €10.2M | €15.8M |
| — attributable to owners | €10.1M | €15.6M |
| — attributable to NCI | €130.0K | €199.0K |
| Total comprehensive income | €10.2M | €15.7M |
| Per share | ||
| Basic EPS | €1.01 | €1.56 |
| Diluted EPS | €0.99 | €1.56 |
| Free cash flow / share | €4.92 | €4.32 |
| Cash flow statement | ||
| Net cash from operating activities | €62.5M | €52.6M |
| Income taxes paid | €9.2M | €12.1M |
| Net cash from investing activities | -€13.0M | -€17.0M |
| Purchase of PP&E (capex) | €11.7M | €8.9M |
| Purchase of intangibles | €313.0K | €181.0K |
| Net cash from financing activities | -€55.9M | -€46.9M |
| Dividends paid | €13.0M | €12.6M |
| Proceeds from borrowings | €70.1M | €97.4M |
| Repayments of borrowings | €69.1M | €92.0M |
| Lease liability payments | €35.5M | €34.2M |
| Balance sheet | ||
| Total assets | €436.8M | €484.7M |
| Non-current assets | €260.6M | €287.4M |
| Property, plant & equipment | €49.4M | €52.2M |
| Right-of-use assets | €152.4M | €177.8M |
| Intangible assets & goodwill | €42.9M | €42.6M |
| Current assets | €176.2M | €197.2M |
| Inventories | €95.4M | €101.5M |
| Trade & other receivables | €17.6M | €21.1M |
| Cash & equivalents | €46.8M | €54.9M |
| Total equity | €94.6M | €97.8M |
| — attributable to owners | €91.9M | €94.5M |
| Non-controlling interests | €2.7M | €3.4M |
| Non-current liabilities | €147.5M | €181.0M |
| Long-term borrowings | €12.7M | €16.6M |
| Lease liabilities (non-current) | €127.0M | €150.3M |
| Current liabilities | €194.7M | €205.9M |
| Short-term borrowings | €29.1M | €24.3M |
| Lease liabilities (current) | €33.1M | €35.2M |
| Trade & other payables | €50.0M | €57.1M |
| Deferred tax liabilities | €17.0K | €146.0K |
| Derived metrics | ||
| Free cash flow | €50.7M | €43.8M |
| Operating margin | 5.4% | 6.3% |
| Net margin | 2.5% | 3.8% |
| Return on equity | 10.8% | 16.2% |
| Cash conversion ratio | 6.12× | 3.33× |
| Capex coverage | 5.32× | 5.94× |
| Other reported items | ||
| Adjustments For Income Tax Expense | €3.8M | €5.7M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €77.0K | €183.0K |
| Adjustments For Sharebased Payments | €688.0K | €659.0K |
| Bank Overdrafts Classified As Cash Equivalents | €169.0K | €252.0K |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €532.0K | €475.0K |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €46.7M | €54.6M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €68.2M | €75.1M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €5.5M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €505.0K | €232.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | €454.0K | €202.0K |
| Comprehensive Income Attributable To Owners of Parent | €9.8M | €15.5M |
| Current Advances | €76.6M | €84.1M |
| Current Tax Assets Current | €2.4M | €5.5M |
| Current Tax Liabilities Current | €534.0K | €1.2M |
| Deferred Tax Assets | €9.8M | €8.7M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €12.6M | €12.6M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €394.0K | €0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€1.5M | €600.0K |
| Equity and Liabilities | €436.8M | €484.7M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €394.0K | €1.2M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €11.0K | -€57.0K |
| Increase Decrease In Cash and Cash Equivalents | -€8.0M | -€10.7M |
| Increase Decrease In Working Capital | -€3.4M | €10.4M |
| Increase Decrease Through Other Distributions To Owners | -€123.0K | €7.7M |
| Increase Decrease Through Sharebased Payment Transactions | €479.0K | €659.0K |
| Increase Decrease Through Transactions With Owners | -€13.4M | -€22.6M |
| Increase Decrease Through Treasury Share Transactions | -€1.0M | -€2.9M |
| Intangible Assets Other Than Goodwill | €331.0K | €333.0K |
| Interest Paid Classified As Financing Activities | €5.2M | €5.5M |
| Interest Revenue Expense | -€5.2M | -€5.5M |
| Issue of Equity | — | €0 |
| Issued Capital | €50.7M | €50.7M |
| Noncurrent Provisions | €4.7M | €4.9M |
| Number of Shares Outstanding | 10.1M | 10.1M |
| Other Adjustments To Reconcile Profit Loss | €100.0K | €357.0K |
| Other Comprehensive Income | €37.0K | -€144.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -€108.0K | €178.0K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €155.0K | -€379.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€108.0K | €178.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €144.0K | -€322.0K |
| Other Current Liabilities | €5.3M | €4.0M |
| Other Current Receivables | €13.9M | €14.3M |
| Other Expense By Nature | €96.5M | €100.7M |
| Other Finance Cost | €3.1M | €665.0K |
| Other Finance Income | €528.0K | €1.5M |
| Other Noncurrent Financial Assets | €5.7M | €5.9M |
| Other Noncurrent Liabilities | €3.1M | €9.0M |
| Other Noncurrent Nonfinancial Assets | €49.0K | €9.0K |
| Other Revenue | €30.3M | €30.9M |
| Payments To Acquire Or Redeem Entitys Shares | €1.0M | €2.4M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €40.0K | €127.0K |
| Revenue From Royalties | €10.3M | €10.7M |
| Revenue From Sale of Goods | €361.9M | €372.5M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €0 | €0 |
| Tax Expense Other Than Income Tax Expense | €5.7M | €5.7M |
Every line item above is a fact tagged in ROCHE BOBOIS's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.